Progressive interstitial lung disease from prolonged methotrexate therapy
- 1 December 1978
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 114 (12) , 1800-1802
- https://doi.org/10.1001/archderm.114.12.1800
Abstract
• Progressive interstitial fibrosis with roentgenographic honeycombing developed in the case of a psoriatic patient who had been on a regimen of methotrexate for 18 years. Examination revealed a combined restrictive and obstructive defect in pulmonary mechanics and severe compromise of gas transfer across the pulmonary alveolar-capillary membrane. Improvement in the level of arterial blood gases and pulmonary diffusing capacity occurred after discontinuation of methotrexate therapy. Interstitial fibrosis of the lung is a potential complication of methotrexate therapy for psoriasis. (Arch Dermatol114:1800-1802, 1978)This publication has 2 references indexed in Scilit:
- Circulating Immune Complexes in the Idiopathic Interstitial PneumoniasNew England Journal of Medicine, 1978
- Methotrexate pneumonitis induced by intrathecal methotrexate therapy.A case report with pharmacokinetic dataCancer, 1976